The eye also presents challenges to drug access from the bloodstream. However, therapeutic agents can be delivered directly to the eye; this is not possible with the brain. Although more invasive ...

Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...

A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the patient's bedside as part of a clinical trial.

The wakeup call came a few years ago, seeing a picture of myself bowling in a cricket tournament in Thailand and wondering ...

Volume of distribution at steady state (L/kg) 187 194 194 Table 2. Changes in cough-related symptoms following treatment with levocloperastine 30, 60 and 120 mg/day for 6 days in patients with ...

Therapeutic Cannabis products are gaining mainstream prominence, especially after the outbreak of the COVID-19 pandemic, owing to factors such as growing stress and anxiety levels, and the ...

By addressing several of the underlying mechanisms of fibromyalgia, PBM can offer promising options as a non-invasive therapeutic approach. It is the first therapeutic laser to be cleared by the ...

Interestingly, this gender-based treatment gap did not significantly vary with patient age, indicating that therapeutic inertia may persist regardless of the woman's stage in life.

D-150 demonstrated robust and durable clinical activity across all wet age-related macular degeneration (wet AMD) patient populations based on ...

Objectives The objectives of this study are to describe the prevalence of therapeutic use exemptions (TUEs ... Substances and methods were categorised as outlined in the List: S1 Anabolic Agents; S2 ...

Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental ...

Volume of distribution at steady state (L/kg) 187 194 194 Table 2. Changes in cough-related symptoms following treatment with levocloperastine 30, 60 and 120 mg/day for 6 days in patients with ...